← All stocks

Stock news timeline · EMCURE

Emcure Pharma

News timeline · Last 30 days

23 Aug 2026 – 21 Sep 2026 · Times in IST

Timeline updates
6
Bullish
1
Neutral
5
Bearish
0
Active days
4

News timeline

Showing 6 of 6 updates · Newest first

Friday, 11 Sep 20261 update

AI sentiment: Neutral 90% confidence

Emcure Allots 11,400 Shares Under ESOS, Share Capital Hits ₹189.71 Cr

Emcure Pharmaceuticals allotted 11,400 equity shares under ESOS 2013 to eligible employees. Post allotment, issued share capital increased to 18,97,10,647 shares, aggregating Rs. 189.71 cr. Source: BSE

Tuesday, 01 Sep 20263 updates

AI sentiment: Neutral 92% confidence

Emcure Pharmaceuticals: Plans Meeting With Analysts and Investors on September 4

AI sentiment: Neutral 92% confidence

Emcure to Host Investor Meet on Sep 4, 2026 in Pune

Emcure Pharmaceuticals announces analyst/investor meet on Sep 4, 2026, in Pune. No unpublished price-sensitive info will be shared during the meeting. Source: BSE

AI sentiment: Bullish 89% confidence

CARE Reaffirms Emcure Ratings; Stable Outlook on Growth, Profit Rise

CARE reaffirmed Emcure Pharmaceuticals' ratings with a stable outlook. Reasons include growth, diversification, profit rise, and strong capital despite increased debt. Source: ScoutQuest

Monday, 31 Aug 20261 update

AI sentiment: Neutral 91% confidence

Emcure Pharma Sets ₹3.60 Dividend, Ex-Date Sept 4

Emcure Pharmaceuticals' ex-dividend date is September 4, for a dividend of ₹3.60/share, payable on October 21. The company has a low payout ratio (7.4% income, 14% cash flow) and 11% EPS growth over five years. Source: Simply Wall Street

Friday, 28 Aug 20261 update

AI sentiment: Neutral 84% confidence

Elara Starts 'Accumulate' on Emcure, Sets ₹2,030 Target

Elara Capital initiates Accumulate rating on Emcure Pharma with ₹2,030 target. The rating reflects a diverse portfolio, strong global growth, and pharma partnerships. Source: ScoutQuest